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Introduction
Colorectal cancer (CRC) is one of the most common malignant tumors and is currently listed third under incidence and second under mortality worldwide. 1 The National Center for Health Statistics in the USA estimates that, in 2014, 71,830 men and 65,000 women will be diagnosed with CRC and 26,270 men and 24,040 women will die of the disease. 2 Worldwide, the prevention and treatment of CRC faces enormous challenges. Development of CRC is closely linked to many environmental and genetic factors, including lack of dietary fiber, overweight and obesity, physical inactivity, a short appendix vermiformis, a high-fat diet, smoking, and excessive alcohol consumption. 3 Genetic factors play an important role, as susceptibility to CRC may result from inherited mutations in genes involved in carcinogen metabolism and DNA repair. 4 It is now widely thought that the pathogenesis of CRC is related to environmental triggers and genetic susceptibility to multifactorial interactions.
Nucleotide excision repair is an important element of genome maintenance that is mainly responsible for repairing DNA adducts and other types of damage that cause helical distortions. 5 A number of enzymes are involved in the nucleotide excision 7 A difference in DNA repair capacity has been proposed to be a contributor to CRC susceptibility. Many studies have focused on the gene loci of XPD Lys751Gln.
To date, many studies focus on the genetic polymorphism of XPD and its contribution to CRC susceptibility; however, due to the interethnic heterogeneity of the disease, the limitations of statistical power in individual studies, small sample sizes, and other factors, the results are inconsistent. To reduce the research bias and improve the effectiveness of statistical correlation analysis, we conducted a comprehensive quantitative meta-analysis of previous results to evaluate the relationship between the XPD Lys751Gln polymorphism and the risk of CRC.
Materials and methods

Publication search
This meta-analysis adhered to the relevant criteria of the Preferred Reporting Items for Systemic Reviews and MetaAnalyses (PRISMA) statement. 8 The 
inclusion and exclusion criteria
In this meta-analysis, publications were included using the following criteria: case-control studies investigating the relationship between the XPD Lys751Gln polymorphism and CRC risk; patients with histologically confirmed CRC; sufficient genotype distribution information in cases and controls; and genotype distribution compliant with the Hardy-Weinberg equilibrium (HWE). The following exclusion criteria were used: abstracts and reviews; study designs other than case-control method; detailed genotype frequency not reported; and repeat or overlapping publications.
Data extraction
Data were independently extracted by two different investigators from all included studies: name of first author, publication year, country or area, characteristics of controls, sources of controls (population-based or hospital-based), genotyping method, fitness of HWE in controls, and genotype distribution. Any discrepancy was resolved through discussion or by a third person.
statistical analysis
The crude odds ratio (OR) and 95% confidence interval (95% CI) were used to assess the strength of the association between the XPD Lys751Gln polymorphism and CRC risk. The pooled ORs were performed in homozygous (Gln-Gln versus Lys-Lys), heterozygous (Lys-Gln versus Lys-Lys), 
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XPD lys751gln polymorphism and colorectal cancer risk and dominant (Lys-Gln + Gln-Gln versus Lys-Lys) models. A chi square-based Q-test was used to test the assumption of heterogeneity. P.0.1 for the Q-test suggested a lack of heterogeneity among studies and required the fixed effects model (the Mantel-Haenszel method) to estimate the pooled OR of each study. 9 Otherwise, the random effect model was used. Egger's test and Begg's funnel plot was plotted to examine the underlying publication bias among the included studies. An asymmetric plot suggested possible publication bias, while P.0.05 suggested no bias. Statistical analyses were performed using Stata statistical software (version 10.0, Stata Corporation, College Station, TX, USA). P,0.05 was considered to be statistically significant, and all P-values were two-sided.
Results
characteristics of studies
In this meta-analysis, eleven case-control studies were included to evaluate the relationship between the XPD Lys751Gln polymorphism and CRC risk, which provided a total of 2,961 cases 11 Hansen et al 12 Stern et al 13 Sliwinski et al 14 Joshi et al 15 Engin et al 16 Jelonek et al 17 Wang et al 18 Procopciuc and Osian and 4,539 controls for the present meta-analysis. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] All cases were histologically confirmed as colon or rectal cancer. There were four studies from Asian populations 10, 13, 18, 20 and seven from Caucasian populations. 11, 12, [14] [15] [16] [17] 19 Among the eleven studies, seven were hospital-based 10, 11, 14, 16, [18] [19] [20] and four were population-based. 12, 13, 15, 17 Controls were mainly healthy populations and were matched for age and gender. Genotyping methods included polymerase chain reaction and restriction fragment length polymorphism and TaqMan in accordance with HWE (see Table 1 ).
Quantitative synthesis
Overall, there was no significant association between the XPD Lys751Gln polymorphism and risk of CRC. The specific results were as follows: homozygous model (Gln-Gln versus Lys-Lys, OR 1.08, P=0.477, 95% CI 0.88-1.33), heterozygous model (Lys-Gln versus Lys-Lys, OR 1.06, P=0.283, 95% CI 0.95-1.19), and dominant model (Lys-Gln + Gln-Gln versus Lys-Lys, OR 0.96, P=0.562, 95% CI 0.87-1.05, Figure 1 ). We performed subgroup analysis, and the results suggested no significant association in any of the genetic models with ethnicity or source of controls (see Table 2 ).
Tests of heterogeneity and publication bias
Due to heterogeneity in the meta-analysis of association between the dominant model and CRC risk (Lys-Gln + Gln-Gln versus Lys-Lys, I 2 =85.3%, P=0.000), a random effects model was adopted for this analysis. Subgroup analysis indicated that ethnicity and source of controls were not significant sources of heterogeneity. The fixed effects model was used for the homozygous and heterozygous models because of the absence of heterogeneity (Gln-Gln versus Lys-Lys, I 2 =29.8%, P=0.171; Lys-Gln versus Lys-Lys, I 2 =0.0%,
P=0.794).
Begg's funnel plot and Egger's test were used to assess the publication bias of the included articles. The shape of the funnel plot was not obviously asymmetric (see Figure 2 ). In addition, Egger's test revealed no evidence of publication bias (P.0.05).
Discussion
The pathogenesis of CRC has not been elucidated, but the following factors are thought to be contributory: diet and carcinogens; chronic colorectal inflammations such as ulcers, polyps, and schistosomiasis; tumor suppressor gene mutations or genetic instability; and colorectal adenomas and other precancerous lesions. [21] [22] [23] [24] Currently, it is generally thought that the occurrence of CRC is a gradual process involving multiple oncogene activations and tumor suppressor gene inactivation. 25, 26 DNA repair systems are the body's main defense barrier for internal and external environmental factors that are sources of genome instability. Defects in these systems or low DNA repair capacity increase 7, 27, 28 XPD participates in unwinding the DNA helix to allow excision of damaged DNA fragments. 29 A study of the XPD gene found that a mutation at the codon 751 allele is most common. 25 Many epidemiological studies have thereafter been indicating the role of Lys751Gln polymorphism on CRC susceptibility, but the result remains controversial.
Thus, our meta-analysis, comprising 2,961 CRC patients and 4,539 controls from eleven studies, was performed to assess precisely the possible association of XPD Lys751Gln polymorphism with susceptibility to CRC. Our meta-analysis suggests that XPD Lys751Gln polymorphism was not associated with CRC risk. In the subgroup analysis, where studies were divided by ethnicity or source of controls, there was still no significant association detected in the homozygous, heterozygous, or dominant model. Meta-analysis is reliant on available published data, and publication bias is common. Through the qualitative funnel plot and quantitative Egger's linear regression, we have shown that there is no significant publication bias in the current study. However, there are some limitations to this meta-analysis. First, the studies included involve only Asian and Caucasian populations, without representation of other racial or ethnic groups, including the African population. Additionally, we could only carry out a subgroup analysis for a large geographical area despite the presence of different national characteristics within a region due to the lack of raw data for each study. Moreover, we could not carry out individual subgroup analysis for patients with colon and colorectal cancer due to the lack of availability of raw data. Finally, the potential effect of gene-gene or gene-environment interactions on the statistical results was not considered.
In summary, our meta-analysis pooled all available data related to potential links between XPD Lys751Gln and CRC, and found no evidence that the polymorphism is associated with CRC risk.
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